Navigation Links
New CPT Code for Automated Point-of-Care Retinal Imaging
Date:6/25/2019

IDx, a privately held artificial intelligence (AI) diagnostics company, announced today that the American Medical Association’s (AMA) Current Procedural Terminology (CPT) Editorial Panel has accepted a new category 1 CPT® code for automated point-of-care retinal imaging. This new code, submitted by the American Academy of Ophthalmology (AAO) with the support of IDx, facilitates correct billing of IDx-DR, an FDA-cleared autonomous AI system that detects diabetic retinopathy, a leading cause of blindness.

“This represents a significant milestone for autonomous AI in health care,” said Michael Abramoff, MD, PhD, founder and CEO of IDx. “By accepting this new CPT code, the AMA’s CPT Editorial panel has established a billing code for an AI-enabled system, which can help foster further adoption of autonomous AI technologies in healthcare. This will make billing the IDx-DR exam more straightforward for our customers, who have been billing for this sight-saving exam.”

The AMA’s CPT Editorial panel grants CPT codes, which are developed and reviewed by clinician experts as part of a transparent and open process, to provide a uniform language for submitting healthcare procedures and services for payor reimbursement. The new CPT code for automated point-of-care retinal imaging, scheduled to be effective in January 2021, will streamline the coding and billing process for healthcare providers using IDx-DR. The code description may be further refined prior to its scheduled implementation.

The AMA also issued a press release earlier this month further outlining policy recommendations for AI in healthcare. That policy includes advocating for “payment and coverage of all health care AI systems that are conditioned on complying with all appropriate federal and state laws and regulations, including but not limited to those governing patient safety, efficacy, equity, truthful claims, privacy, and security as well as state medical practice and licensure laws,” among other criteria.

“It is exciting to see that our work aligns with the AMA’s policy recommendations,” said Abramoff. “When we developed and validated IDx-DR, it was our priority to show that the system was safe, effective, and equitable for use in patient care. We are thankful the AMA sees the value of supporting payment and coverage for AI health systems that meet rigorous validation. It is also incredibly important that AMA recommends autonomous AI developers assume accountability and liability for the system output, which we have been advocating for and practicing for years."

IDx-DR received a historic FDA clearance in 2018 when it became the first autonomous AI diagnostic system to be cleared for use without needing a physician to interpret the results. This enables non-eye care providers to use IDx-DR to make an immediate diagnostic assessment for diabetic retinopathy at the point of care, without requiring telemedicine or specialist review.

More than 30 million Americans have diabetes, and an estimated 24,000 lose vision each year from diabetic retinopathy, a complication of diabetes. If caught in its early stages, vision loss and blindness are almost entirely preventable, yet only about half of people with diabetes get regular eye exams. By enabling frontline healthcare providers to administer a diabetic retinopathy exam during a routine office visit, IDx-DR increases patient access to this potentially sight-saving exam.

IDx-DR has been used to test thousands of people with diabetes across the U.S. and Europe to date and is currently in use across a wide range of frontline care settings, including endocrinology, internal medicine, and community health clinics.

About IDx
IDx is a leading AI diagnostics company on a mission to transform the quality, accessibility, and affordability of healthcare. Founded in 2010 by a team of world-renowned clinician scientists, the company is focused on developing clinically-aligned autonomous AI that detect disease in medical images. By enabling diagnostic assessment in primary care settings, IDx aims to increase patient access to high-quality, affordable disease detection.

The company’s first product, IDx-DR, is an FDA-cleared AI-based diagnostic system designed for use at the front lines of care to detect diabetic retinopathy. IDx-DR is intended for use by health care providers to automatically detect more than mild diabetic retinopathy in adults (22 years of age or older) diagnosed with diabetes who have not been previously diagnosed with diabetic retinopathy. IDx-DR is indicated for use with the Topcon NW400, an easy to use and highly accurate robotic fundus camera.

IDx is developing additional AI-based diagnostic systems for the detection of macular degeneration, glaucoma, Alzheimer’s disease, cardiovascular disease, and stroke risk.

IDx
2300 Oakdale Blvd
Coralville, IA 52241
Phone: 319-248-5620
http://www.eyediagnosis.net
IDx Contact:
Laura Shoemaker
Director of Marketing Communications
1-319-248-5620
lshoemaker@eyediagnosis.net

Read the full story at https://www.prweb.com/releases/new_cpt_code_for_automated_point_of_care_retinal_imaging/prweb16403368.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine news :

1. Practice-Web Creates the Next Generation of Automated Reminder Systems
2. CHICA, automated system developed by Regenstrief and IU, improves autism screening rate
3. University of California Researchers Validate Automated Breast Density Software
4. Verde Pointe Dental Associates Announce Adding a Custom Automated Prosthetics' 3Shape Trios Color Scanner
5. Automated system could efficiently identify high-risk osteoporosis patients
6. Automated link to national intervention guidance helps doctors interpret FRAX results
7. Computer-automated, time-lapse embryo photography may increase success of IVF
8. Park NX-Wafer for Wafer-Fab Manufacturing Fully Automates Semiconductor Industry’s Bare Wafer Automated Defect Review Process, Increases Throughput by 1,000 Percent
9. Study shows promise in automated reasoning, hypothesis generation over complete medical literature
10. Ontraport: Review Exposes Automated Platform for Online Marketing Management
11. Catalent Supports Eli Lilly's Growing Global Clinical Trials Needs with New Investment in Automated Packaging Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2019)... (PRWEB) , ... July 10, 2019 , ... ... to the role of Client Services Manager and will lead the growing team ... new role at First Healthcare Compliance and look forward to further developing new ...
(Date:7/9/2019)... ... 09, 2019 , ... Human cytomegalovirus (HCMV) may not be a household name ... Veterinary Medicine at UMD, half of the population walking around campus is likely to ... of your life and can flare up whenever your immune system is severely compromised, ...
(Date:7/9/2019)... ... July 09, 2019 , ... A2LA is pleased to announce the accreditation ... oils, and solids. GEL Laboratories is based in Charleston, South Carolina, and is the ... first laboratory in the field of environmental testing to expand their scope to include ...
(Date:7/9/2019)... ... July 09, 2019 , ... Anxiety help can often feel out of reach ... A new online therapy platform called Emote seeks to change this for ... through their mobile device, tablet or computer to highly qualified licensed therapists online. Easily ...
(Date:7/9/2019)... ... 09, 2019 , ... Advanced Intelligent Systems (AIS) , ... shortage problems in agriculture, will demonstrate their flagship autonomous custom robot, called ... North America’s leading trade show for the horticulture industry. , “We are ...
Breaking Medicine News(10 mins):
(Date:7/10/2019)... ... July 10, 2019 , ... DidCBDWork.com is the first website aimed ... months, does CBD actually work? It seems like depending on what you read, CBD ... instead aims to get testimonials of real CBD users, who are attempting to ease ...
(Date:7/10/2019)... ... 2019 , ... Successful actor and philanthropist, Laurence Fishburne, is ... of healthcare and how these costs affect American consumers. , The episode addresses ... painful decisions families face between paying for essential health services they require and ...
(Date:7/9/2019)... ... 10, 2019 , ... Women’s Excellence’s goal is treating the ... in-depth interpretation of symptoms, evaluate a women’s lifestyle, and conduct physical examination and ... wants and needs for your menopausal management. Our team specializes in bioidentical ...
Breaking Medicine Technology: